PT1812590E - Métodos e reagentes para a detecção de melanoma - Google Patents

Métodos e reagentes para a detecção de melanoma Download PDF

Info

Publication number
PT1812590E
PT1812590E PT05791715T PT05791715T PT1812590E PT 1812590 E PT1812590 E PT 1812590E PT 05791715 T PT05791715 T PT 05791715T PT 05791715 T PT05791715 T PT 05791715T PT 1812590 E PT1812590 E PT 1812590E
Authority
PT
Portugal
Prior art keywords
melanoma
reagents
detection
methods
assay
Prior art date
Application number
PT05791715T
Other languages
English (en)
Inventor
Yixin Wang
Dimitri Talantov
Abhijit Mazumder
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of PT1812590E publication Critical patent/PT1812590E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
PT05791715T 2004-06-25 2005-06-24 Métodos e reagentes para a detecção de melanoma PT1812590E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58290604P 2004-06-25 2004-06-25

Publications (1)

Publication Number Publication Date
PT1812590E true PT1812590E (pt) 2009-07-06

Family

ID=35782385

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05791715T PT1812590E (pt) 2004-06-25 2005-06-24 Métodos e reagentes para a detecção de melanoma

Country Status (16)

Country Link
EP (1) EP1812590B1 (pt)
JP (1) JP2008504034A (pt)
KR (1) KR20070048701A (pt)
CN (1) CN101258249A (pt)
AT (1) ATE428808T1 (pt)
AU (1) AU2005258331B2 (pt)
BR (1) BRPI0512587A (pt)
CA (1) CA2572338A1 (pt)
DE (1) DE602005013998D1 (pt)
DK (1) DK1812590T3 (pt)
ES (1) ES2323972T3 (pt)
IL (1) IL180208A0 (pt)
MX (1) MX2007000291A (pt)
NZ (1) NZ552324A (pt)
PT (1) PT1812590E (pt)
WO (1) WO2006002433A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080038725A1 (en) 2005-06-20 2008-02-14 Yuling Luo Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
EP1934378A4 (en) * 2005-09-19 2008-10-29 Veridex Llc METHOD FOR THE DIAGNOSIS OF PANCREATIC CANCER
FR2890859B1 (fr) 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase
US20100029504A1 (en) 2007-01-16 2010-02-04 Phigenix, Inc. Detecting pax2 for the diagnosis of breast cancer
JP2007289063A (ja) * 2006-04-25 2007-11-08 Shiseido Co Ltd しみ部位亢進遺伝子群を指標とした皮膚しみ形成予知方法、皮膚しみ形成抑制剤のスクリーニング方法
US7851144B2 (en) 2006-08-18 2010-12-14 The University Of Washington Compositions and methods for detecting cancer
CA2677118A1 (en) * 2007-02-01 2008-08-07 Veridex, Llc Methods and materials for identifying the origin of a carcinoma of unknown primary origin
EP2162552A4 (en) * 2007-05-11 2010-06-30 Univ Johns Hopkins BIOMARKERS FOR MELANOMES
AU2009246180B2 (en) 2008-05-14 2015-11-05 Dermtech International Diagnosis of melanoma and solar lentigo by nucleic acid analysis
IL206810A (en) * 2009-07-08 2015-07-30 Janssen Diagnostics Llc Methods for identifying melanoma and kits for using these methods
JP2013013327A (ja) * 2009-10-29 2013-01-24 Actgen Inc Mansc1蛋白質に結合し、抗癌活性を有する抗体
US20120071343A1 (en) * 2010-09-20 2012-03-22 Advanced Cell Diagnostics, Inc Biomarkers for differentiating melanoma from benign nevus in the skin
ES2648564T3 (es) 2010-10-21 2018-01-04 Advanced Cell Diagnostics, Inc. Método ultrasensible para la detección in situ de ácidos nucleicos
CA2875710C (en) 2012-06-22 2021-06-29 John Wayne Cancer Institute Molecular malignancy in melanocytic lesions
ES2893100T3 (es) 2015-10-12 2022-02-08 Advanced Cell Diagnostics Inc Detección in situ de variantes de nucleótidos en muestras con un elevado nivel de ruido, y composiciones y métodos relacionados con ésta
CN105331686B (zh) * 2015-10-21 2018-09-21 中国科学院生物物理研究所 Myosin9b蛋白特异性抗体的制备及Myosin9b基因家族变化在肿瘤诊断及预后中的应用
CN110088136A (zh) * 2016-10-13 2019-08-02 达纳-法伯癌症研究所有限公司 使用基因表达签名预测黑素瘤中对于ctla4封锁的应答和耐药性的组合物和方法
CN106884018B (zh) * 2017-01-19 2021-03-23 江苏大学 一种检测致癌蛋白表皮生长因子受体的试剂及试剂盒
AU2019222462A1 (en) 2018-02-14 2020-09-03 Dermtech, Inc. Novel gene classifiers and uses thereof in non-melanoma skin cancers
CN109371113A (zh) * 2018-10-29 2019-02-22 湖南健基生物技术有限公司 一种检测人类apoe和slco1b1基因多态性的组合物、试剂盒、样品处理方法和应用
EP3948290A4 (en) 2019-03-26 2023-08-09 Dermtech, Inc. NEW GENE CLASSIFIERS AND THEIR USES FOR SKIN CANCERS
CN112773730B (zh) * 2021-01-28 2023-01-03 南昌大学 微小rna在美白护肤产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310652A (en) * 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
DE19949594A1 (de) * 1999-10-14 2001-04-26 Deutsches Krebsforsch Rekombinante attenuierte Listerien zur Immuntherapie
JP2004509612A (ja) * 2000-06-05 2004-04-02 アバロン ファーマシューティカルズ ガン遺伝子決定および特徴的な遺伝子群を用いた治療用スクリーニング
WO2002027028A1 (en) * 2000-09-28 2002-04-04 Atairgin Technologies, Inc. A method of determining tumor characteristics by determining abnormal copy number or expression level of lipid-associated genes
AU2003268275C1 (en) * 2002-08-29 2010-04-01 Cytocure Llc Methods for up-regulating antigen expression in tumors
US20060188889A1 (en) * 2003-11-04 2006-08-24 Christopher Burgess Use of differentially expressed nucleic acid sequences as biomarkers for cancer

Also Published As

Publication number Publication date
KR20070048701A (ko) 2007-05-09
WO2006002433A2 (en) 2006-01-05
MX2007000291A (es) 2007-08-07
IL180208A0 (en) 2007-07-04
AU2005258331A1 (en) 2006-01-05
WO2006002433A3 (en) 2006-08-24
ES2323972T3 (es) 2009-07-28
CN101258249A (zh) 2008-09-03
JP2008504034A (ja) 2008-02-14
NZ552324A (en) 2009-11-27
BRPI0512587A (pt) 2007-09-18
EP1812590A2 (en) 2007-08-01
ATE428808T1 (de) 2009-05-15
AU2005258331B2 (en) 2009-12-10
EP1812590B1 (en) 2009-04-15
DE602005013998D1 (de) 2009-05-28
DK1812590T3 (da) 2009-07-13
CA2572338A1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
IL180208A0 (en) Methods and reagents for the detection of melanoma
TW200636245A (en) Colorimetric sensors constructed of diacetylene materials
AU2002352745A1 (en) Method of detection of prostate cancer
WO2004030511A3 (en) Prostate cancer biomarkers
WO2005022293A3 (en) Method for a classification guilty knowledge test and integrated system for detection of deception and information
GB2449043A (en) Water soluble conjugates for electrochemical detection
WO2006012646A3 (en) Amacr cancer markers
ATE322014T1 (de) Krebsnachweisverfahren und reagenzien
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2006054296A3 (en) Methods of detecting prostate cancer
DK1694775T3 (da) Reagens til påvisning af en analyt
WO2008130887A8 (en) Biomarkers for follicular thyroid carcinoma and methods of of use
IL179441A0 (en) Hif prolyl hydroxylase activity assay
WO2007058629A3 (en) Influenza a virus detection method and kit therefor
WO2005057166A3 (en) Detection of conformationally altered proteins and prions
WO2007089372A3 (en) A position detecting system that self-monitors for connectivity faults
WO2006034456A3 (en) Compositions and methods for detecting and treating tumors
EA200300880A1 (ru) Способ детекции нуклеотидного полиморфизма
NO20052553L (no) Cobalaminanalyse.
EP1702982A4 (en) METHOD FOR DETECTING LIVER CANCER, DIAGNOSTIC FOR LIVER CANCER AND REMEDIES AGAINST CANCER
DE60314290D1 (de) Aus polydiacetylen hergestellte kolorimetrische sensoren.
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2001083816A3 (en) Method for detecting tumors
WO2006031831A3 (en) Methods for the detection of ovarian cancer
TW200721706A (en) Detecting presence/absence of an information signal